This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Trulieve Cannabis (TRUL) Panoramica del titolo
Trulieve Cannabis Corp. opera come rivenditore di cannabis. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 3/6 |
| Crescita futura | 3/6 |
| Prestazioni passate | 0/6 |
| Salute finanziaria | 5/6 |
| Dividendi | 0/6 |
TRUL Community Fair Values
Create NarrativeSee what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di Trulieve Cannabis Corp.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | CA$16.14 |
| Massimo di 52 settimane | CA$18.50 |
| Minimo di 52 settimane | CA$4.45 |
| Beta | 1.86 |
| Variazione di 1 mese | 46.06% |
| Variazione a 3 mesi | 83.83% |
| Variazione di 1 anno | 215.85% |
| Variazione a 3 anni | 202.81% |
| Variazione a 5 anni | -63.40% |
| Variazione dall'IPO | 61.72% |
Notizie e aggiornamenti recenti
Recent updates
Aggiornamento della narrazione • May 30
TRUL: Schedule III Reclassification Pathway Will Drive Future Multiple Re Rating
Narrative Update on Trulieve Cannabis Analysts have raised their price target on Trulieve Cannabis by CA$8, reflecting updated assumptions for fair value, revenue growth, profit margins, and future P/E following recent sector research and regulatory commentary on cannabis rescheduling. Analyst Commentary Street research around Trulieve Cannabis has centered on how potential cannabis rescheduling could affect valuation, tax burdens, and long term earnings power.Aggiornamento della narrazione • Apr 23
TRUL: Schedule III Shift And Repriced P E Multiple Will Drive Upside
Analysts raised their price target for Trulieve Cannabis to CA$15.26 from CA$14.95, citing updated assumptions based on higher modeled revenue growth, stronger profit margins, and a more moderate future P/E multiple. Analyst Commentary Street research on the broader equity market has included several cautious revisions and lower price targets, which can help frame how bearish analysts might approach a stock like Trulieve Cannabis.
Aggiornamento della narrazione • Apr 08
TRUL: Higher Margin Profile And Rich Future P/E May Support Repricing
Analysts have lifted their fair value estimate for Trulieve Cannabis to CA$20.36 from CA$19.53, citing updated assumptions that reflect more conservative revenue growth, a higher profit margin profile, and a very large future P/E multiple that aligns with recent Street research patterns of recalibrating price targets while keeping core views intact. Analyst Commentary Street research across sectors shows a pattern of price target resets that keep long term theses largely intact, and this context helps frame how to read the updated fair value for Trulieve Cannabis.Aggiornamento della narrazione • Mar 24
TRUL: Schedule III Shift And Lower P E Multiple Will Drive Upside
Analysts have nudged their fair value price target for Trulieve Cannabis to CA$14.95, reflecting updated assumptions for slightly higher revenue growth, modestly improved profit margins, and a lower future P/E multiple in their models. Analyst Commentary While the latest fair value update suggests analysts see some improvement in Trulieve Cannabis' revenue and margin profile, there is still a clear undercurrent of caution in recent research across adjacent data and credit reporting names that can inform how you think about risk.Aggiornamento della narrazione • Mar 10
TRUL: Schedule III Shift And Higher P E Assumptions Will Drive Future Upside
Analysts have slightly raised their fair value estimate for Trulieve Cannabis to about CA$14.95 from CA$14.69, reflecting updated assumptions around slower revenue growth, tighter profit margins and a much higher future P/E multiple that mirrors recent Street work, where price targets have been adjusted while views on long term earnings power and business mix continue to evolve. Analyst Commentary Street research around information services and data providers has recently highlighted how quickly sentiment can shift when investors question earnings durability, pricing power or the impact of new technology.Aggiornamento della narrazione • Feb 24
TRUL: Rescheduling To Schedule III Will Shape Future Upside Potential
Analysts have trimmed their price target on Trulieve Cannabis by a small amount to reflect a slightly lower fair value estimate of CA$14.69. This incorporates updated assumptions that include modestly adjusted revenue growth, profit margin outlook and future P/E expectations.Articolo di analisi • Feb 12
Some Confidence Is Lacking In Trulieve Cannabis Corp. (CSE:TRUL) As Shares Slide 30%
The Trulieve Cannabis Corp. ( CSE:TRUL ) share price has softened a substantial 30% over the previous 30 days, handing...Aggiornamento della narrazione • Feb 09
TRUL: Rescheduling To Schedule III Will Support Higher Future Earnings Multiples
Analysts have slightly raised their fair value estimate for Trulieve Cannabis to $19.53 from $19.06, citing updated assumptions around the discount rate, revenue growth, profit margins, and future P/E levels. What's in the News President Trump directed the Attorney General to complete the rulemaking process to reschedule marijuana to Schedule III of the Controlled Substances Act, which would apply to companies such as Trulieve Cannabis that operate in the sector (Marijuana Herald).Aggiornamento della narrazione • Jan 25
TRUL: Future Rescheduling And Tax Relief Prospects Will Shape Upside Potential
Analysts have trimmed their fair value estimate for Trulieve Cannabis by about $0.12 to roughly $14.78, reflecting updated assumptions around slightly higher revenue growth, a wider profit margin profile, and a lower future P/E multiple. Analyst Commentary Some bearish analysts are using the latest fair value trim as a reminder that execution and growth expectations for Trulieve Cannabis still carry meaningful risk, even with a higher revenue and margin outlook built into the model.Aggiornamento della narrazione • Jan 11
TRUL: Retail Expansion And Rescheduling Progress Will Support Higher Future Earnings Multiples
Analysts have made a small upward adjustment to their Trulieve Cannabis fair value estimate, reflecting only modest tweaks to long term profit margin and future P/E assumptions rather than a wholesale shift in their outlook. Analyst Commentary Recent Street research around comparable business services and data providers offers some useful clues for how analysts may be thinking about Trulieve Cannabis valuation and execution, even though the coverage is focused on different companies.Aggiornamento della narrazione • Dec 27
TRUL: Retail Expansion Into New States Will Drive Future Earnings Multiples
Analysts nudged their price target on Trulieve Cannabis slightly higher, by about $0.16, as they factor in stronger multi year revenue growth, improving profit margins, and a more reasonable future earnings multiple, while still maintaining a similar discount rate framework. Analyst Commentary Recent commentary around Trulieve Cannabis reflects a more constructive, yet still measured, stance as analysts incorporate updated assumptions for growth, profitability, and regulatory visibility into their valuation work.Articolo di analisi • Dec 22
Trulieve Cannabis Corp.'s (CSE:TRUL) Shares Climb 55% But Its Business Is Yet to Catch Up
Trulieve Cannabis Corp. ( CSE:TRUL ) shareholders would be excited to see that the share price has had a great month...Aggiornamento della narrazione • Dec 13
TRUL: Future Execution And Regulatory Shifts Will Shape Risk-Reward Balance
Analysts have lifted their price target on Trulieve Cannabis to approximately $14.90 from about $11.01, citing stronger expected revenue growth, improved profit margins, and a more reasonable future P/E multiple despite a slightly higher discount rate. Analyst Commentary Bearish analysts acknowledge Trulieve Cannabis's improved outlook but remain wary of execution and valuation risks in a still evolving regulatory and competitive landscape.Aggiornamento della narrazione • Nov 22
TRUL: Retail Expansion And New Markets Will Support Share Price Momentum
The analyst price target for Trulieve Cannabis has decreased slightly from $19.16 to $18.87. Analysts cite modest adjustments to profit margin expectations and valuation metrics as reasons for the change.Articolo di analisi • Nov 08
Trulieve Cannabis Corp. (CSE:TRUL) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Shareholders might have noticed that Trulieve Cannabis Corp. ( CSE:TRUL ) filed its quarterly result this time last...Articolo di analisi • Nov 07
Some Trulieve Cannabis Corp. (CSE:TRUL) Shareholders Look For Exit As Shares Take 29% Pounding
The Trulieve Cannabis Corp. ( CSE:TRUL ) share price has softened a substantial 29% over the previous 30 days, handing...Aggiornamento della narrazione • Nov 07
TRUL: Future Market Expansion Will Drive Share Price Momentum
Trulieve Cannabis’s analyst price target has been raised from $17.89 to $19.16. Analysts cite improved revenue growth projections and stable profit margins as key drivers for the upward revision.Articolo di analisi • Oct 27
We Think Trulieve Cannabis (CSE:TRUL) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Articolo di analisi • Aug 29
Trulieve Cannabis Corp.'s (CSE:TRUL) Shares Climb 97% But Its Business Is Yet to Catch Up
Trulieve Cannabis Corp. ( CSE:TRUL ) shares have continued their recent momentum with a 97% gain in the last month...Articolo di analisi • Jul 11
Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 28%
Trulieve Cannabis Corp. ( CSE:TRUL ) shares have continued their recent momentum with a 28% gain in the last month...Articolo di analisi • Jun 12
Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Nuova narrazione • Mar 25
Adult-Use Cannabis Expansion In Florida And Pennsylvania Will Broaden Markets
Strategic retail expansion and new market entry in key states could significantly boost revenue and market share by tapping into adult-use markets.Articolo di analisi • Jan 10
Here's Why Trulieve Cannabis (CSE:TRUL) Has A Meaningful Debt Burden
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Articolo di analisi • Dec 05
More Unpleasant Surprises Could Be In Store For Trulieve Cannabis Corp.'s (CSE:TRUL) Shares After Tumbling 56%
Trulieve Cannabis Corp. ( CSE:TRUL ) shares have had a horrible month, losing 56% after a relatively good period...Articolo di analisi • Sep 04
Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 47%?
Key Insights The projected fair value for Trulieve Cannabis is CA$24.05 based on 2 Stage Free Cash Flow to Equity...Articolo di analisi • Jun 15
Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Trulieve Cannabis Corp. ( CSE:TRUL ) shareholders won't be pleased to see that the share price has had a very rough...Articolo di analisi • Jun 06
Trulieve Cannabis Corp.'s (CSE:TRUL) CEO Will Probably Struggle To See A Pay Rise This Year
Key Insights Trulieve Cannabis' Annual General Meeting to take place on 12th of June Salary of US$750.0k is part of CEO...Articolo di analisi • May 01
Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 38%?
Key Insights The projected fair value for Trulieve Cannabis is CA$32.01 based on 2 Stage Free Cash Flow to Equity...Articolo di analisi • Mar 31
Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%
Trulieve Cannabis Corp. ( CSE:TRUL ) shares have continued their recent momentum with a 26% gain in the last month...Articolo di analisi • Feb 15
Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Articolo di analisi • Jan 16
There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump
The Trulieve Cannabis Corp. ( CSE:TRUL ) share price has done very well over the last month, posting an excellent gain...Rendimenti per gli azionisti
| TRUL | CA Pharmaceuticals | CA Mercato | |
|---|---|---|---|
| 7D | 16.9% | 8.0% | -0.6% |
| 1Y | 215.9% | 56.8% | 29.0% |
Ritorno vs Industria: TRUL ha superato il Canadian Pharmaceuticals che ha restituito 56.8 % nell'ultimo anno.
Rendimento vs Mercato: TRUL ha superato il mercato Canadian che ha restituito 29 % nell'ultimo anno.
Volatilità dei prezzi
| TRUL volatility | |
|---|---|
| TRUL Average Weekly Movement | 15.1% |
| Pharmaceuticals Industry Average Movement | 10.2% |
| Market Average Movement | 9.7% |
| 10% most volatile stocks in CA Market | 16.5% |
| 10% least volatile stocks in CA Market | 3.7% |
Prezzo delle azioni stabile: Negli ultimi 3 mesi il prezzo delle azioni di TRUL è stato volatile rispetto al mercato Canadian.
Volatilità nel tempo: La volatilità settimanale ( 15% ) di TRUL è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni Canadian.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1940 | 5,000 | Kim Rivers | www.trulieve.com |
Trulieve Cannabis Corp. opera come rivenditore di cannabis. L'azienda coltiva, lavora e produce prodotti a base di cannabis e distribuisce i suoi prodotti ai suoi dispensari, oltre che tramite consegna a domicilio. Vende fiori, edibili, concentrati e accessori con i marchi Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers e Roll One.
Trulieve Cannabis Corp. Riepilogo dei fondamenti
| TRUL statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | CA$3.10b |
| Utili (TTM) | -CA$106.04m |
| Ricavi(TTM) | CA$1.63b |
1.9x
Rapporto P/S-29.3x
Rapporto P/ETRUL è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| TRUL Conto economico (TTM) | |
|---|---|
| Ricavi | US$1.17b |
| Costo del fatturato | US$472.15m |
| Profitto lordo | US$698.03m |
| Altre spese | US$774.07m |
| Utili | -US$76.04m |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | -0.40 |
| Margine lordo | 59.65% |
| Margine di profitto netto | -6.50% |
| Rapporto debito/patrimonio netto | 25.3% |
Come si è comportato TRUL nel lungo periodo?
Vedi performance storica e confrontoAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/06/11 01:39 |
| Prezzo dell'azione a fine giornata | 2026/06/09 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; disponiamo inoltre di guide su come utilizzare i nostri report e di tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Trulieve Cannabis Corp. è coperta da 16 analisti. 7 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Aaron Grey | Alliance Global Partners |
| Frederico Yokota Choucair Gomes | ATB Cormark |
| Russell Stanley | Beacon Securities Limited |